PNAA
Pictet North America Advisors’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.69M | Sell |
62,331
-6,967
| -10% | -$748K | 0.67% | 39 |
|
|
2025
Q1 | $6.99M | Sell |
69,298
-8,829
| -11% | -$891K | 0.7% | 41 |
|
|
2024
Q4 | $6.98M | Buy |
78,127
+1,837
| +2% | +$164K | 0.66% | 45 |
|
|
2024
Q3 | $6.39M | Buy |
76,290
+1,032
| +1% | +$86.5K | 0.63% | 42 |
|
|
2024
Q2 | $5.8M | Buy |
75,258
+2,531
| +3% | +$195K | 0.63% | 46 |
|
|
2024
Q1 | $4.98M | Sell |
72,727
-7,272
| -9% | -$498K | 0.56% | 40 |
|
|
2023
Q4 | $4.62M | Sell |
79,999
-298
| -0.4% | -$17.2K | 0.6% | 41 |
|
|
2023
Q3 | $4.24M | Sell |
80,297
-8,024
| -9% | -$424K | 0.6% | 40 |
|
|
2023
Q2 | $4.78M | Buy |
88,321
+1,931
| +2% | +$104K | 0.66% | 33 |
|
|
2023
Q1 | $4.32M | Sell |
86,390
-2,050
| -2% | -$103K | 0.7% | 34 |
|
|
2022
Q4 | $4.09M | Sell |
88,440
-5,099
| -5% | -$236K | 0.7% | 33 |
|
|
2022
Q3 | $3.62M | Sell |
93,539
-2,601
| -3% | -$101K | 0.58% | 35 |
|
|
2022
Q2 | $3.58M | Sell |
96,140
-4,298
| -4% | -$160K | 0.47% | 41 |
|
|
2022
Q1 | $4.45M | Sell |
100,438
-7,226
| -7% | -$320K | 0.52% | 39 |
|
|
2021
Q4 | $4.57M | Buy |
107,664
+4,020
| +4% | +$171K | 0.45% | 42 |
|
|
2021
Q3 | $4.5M | Buy |
103,644
+565
| +0.5% | +$24.5K | 0.44% | 43 |
|
|
2021
Q2 | $4.41M | Buy |
103,079
+980
| +1% | +$41.9K | 0.46% | 40 |
|
|
2021
Q1 | $3.95M | Buy |
102,099
+3,202
| +3% | +$124K | 0.46% | 42 |
|
|
2020
Q4 | $3.56M | Buy |
+98,897
| New | +$3.56M | 0.45% | 37 |
|